Washington et al. v. Food and Drug Administration et al.

Why this Matters:

The Plaintiffs allege that the Food and Drug Administration (FDA) violated the Administrative Procedure Act and the Equal Protection Clause of the U.S. Constitution by subjecting mifepristone to burdensome requirements that make the drug extremely difficult to access and prescribe. This appeal addresses whether the district court was correct in denying a group of states’ motion to intervene in the case.

Potential Impact:

Unnecessary restrictions on safe and effective drugs can create obstacles for doctors to promote medically appropriate care and jeopardize the health and safety of patients seeking medication for abortion services.